1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with benzyl isothiocyanate in 1 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (benzyl isothiocyanate) | Trials (benzyl isothiocyanate) | Recent Studies (post-2010) (benzyl isothiocyanate) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 296 | 0 | 157 |
| Protein | Taxonomy | 1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50) | benzyl isothiocyanate (IC50) |
|---|---|---|---|
| Macrophage migration inhibitory factor | Homo sapiens (human) | 0.62 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sahu, RP | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and benzyl isothiocyanate
| Article | Year |
|---|---|
Expression of the platelet-activating factor receptor enhances benzyl isothiocyanate-induced apoptosis in murine and human melanoma cells.
Topics: Animals; Apoptosis; Azepines; Cell Line; Cell Proliferation; Gene Expression Regulation; Humans; Isothiocyanates; Melanoma; Mice; Platelet Activating Factor; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Reactive Oxygen Species; Receptors, G-Protein-Coupled; Signal Transduction; Triazoles | 2015 |